The North America cell therapy market is expected to reach US$ 5,740.14 million by 2027 from US$ 3,262.56 million in 2019. The market is estimated to grow at a CAGR of 7.4% from 2020 to 2027.
The growth of the market in the region is driven by the factors, such as growing collaborative efforts to promote cell therapy, and developments in cell therapy against COVID–19. However, stringent regulations is likely to restraint the market growth during the forecast period.The significantly growing development and demand for cell therapy across the region have enhanced collaborative efforts between public and private organizations. For instance, in June 2020, the CCRM, a Canadian not-for-profit organization which is funded by the Canadian Government has renewed its agreement with Cytiva, formerly part of GE Healthcare Life Sciences, to continue operation of the Centre for Advanced Therapeutic Cell Technologies (CATCT). The two organizations have enhanced the development and acceptance of cell manufacturing technologies for innovative regenerative medicine-based therapies. In 2016, CATCT was formed by the collaborative efforts of CCRM and Cytiva. The Federal Economic Development Agency initially funded the collaboration for Southern Ontario. Since then, CATCT has expertise in immune-oncology, viral vectors, media development, scale-up processes, and analytics. In addition, in August 2019, CCRM announced to offer support for manufacturing infrastructure and downstream processing. Whereas, Cytiva will provide expertise in manufacturing processes, access to use specialized tools and technologies.
Similarly, in April 2018, STEMCELL Technologies has announced signing an agreement with Canada and British Columbia governments to expand the manufacturing facility in Burnaby, B.C. Under the contract, STEMCELL technologies were to receive US$ 35 million (CAD$ 45 million) funds as joint funding. Moreover, in 2001, Stem Cell Network (SCN), a non-profit organization, was established for regenerative medicine research and training for the next generation and outreach across Canada. The research and development of cell therapies and regenerative medicine are supported by other organizations such as C3i, CellCAN, BioCanRx, adMare BioInnovations, Ontario Institute for Regenerative Medicine (OIRM), and ThéCell. Thus, it is expected that growing collaborative efforts to promote cell therapy are likely to enhance the growth of the North America cell therapy market in the coming near future.
North America Cell Therapy Market Revenue and Forecast to 2027 (US$ Million)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
North America Cell Therapy – Market Segmentation
North America Cell Therapy Market– by Therapy Type
- Allogeneic
- Autologous
North America Cell Therapy Market– by Product
- Consumables
- Equipment
- Systems and Software
North America Cell Therapy Market– by Technology
- Viral Vector Technology
- Genome Editing Technology
- Somatic Cell Technology
- Cell Immortalization Technology
- Cell Plasticity Technology
- Three-Dimensional Technology
North America Cell Therapy Market– by Application
- Oncology
- Cardiovascular
- Orthopedic
- Wound Management
- Other Applications
North America Cell Therapy Market– by End User
- Research Institutes
- Hospitals
- Others
Company Profiles
- Vericel Corporation
- MEDIPOST
- NuVasive, Inc
- Mesoblast Limited
- Smith & Nephew
- Bristol-Myers Squibb Company
- Stemedica Cell Technologies, Inc
- Castle Creek Biosciences, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Therapy Type, Product, Technology, Application, and End User, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North American Cell Therapy Market– By Therapy Type
1.3.2 North American Cell Therapy Market– By Product
1.3.3 North American Cell Therapy Market – By Technology
1.3.4 North American Cell Therapy Market – By Application
1.3.5 North American Cell Therapy Market – By End User
1.3.6 North American Cell Therapy Market– By Region
2. Cell Therapy Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Cell Therapy – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Expert Opinion
5. North America Cell Therapy Market – Industry Dynamics
5.1 Key Drivers
5.1.1 Growing Collaborative Efforts to Promote Cell Therapy
5.1.2 Developments in Cell Therapy Against COVID–19
5.2 Key Market Restraints
5.2.1 Stringent Regulations
5.3 Key Market Opportunities
5.3.1 Focus on Cell Therapy to Treat Diabetes
5.4 Future Trends
5.4.1 Shift Toward Automated Cell Therapy Manufacturing
5.5 Impact Analysis
6. Cell Therapy Market – Regional Analysis
6.1 North America Cell Therapy Market Revenue Forecast And Analysis
6.2 Market Positioning of Key Players
7. Cell Therapy Market Analysis – By Therapy Type
7.1 Overview
7.2 Cell Therapy Market Revenue Share, by Therapy Type, 2019 and 2027 (%)
7.2.1 North America Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
7.3 Allogeneic
7.3.1 Overview
7.3.2 Allogeneic: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Autologous
7.4.1 Overview
7.4.2 Autologous: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
8. Cell Therapy Market – By Product
8.1 Overview
8.2 Cell Therapy Market, by Product, 2019 and 2027 (%)
8.2.1 North America Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
8.3 Consumables
8.3.1 Overview
8.3.2 Consumables: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Equipment
8.4.1 Overview
8.4.2 Equipment: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Systems and Software
8.5.1 Overview
8.5.2 Systems and Software: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
9. Cell Therapy Market – By Technology
9.1 Overview
9.2 Cell Therapy Market, by Technology, 2019 and 2027 (%)
9.2.1 North America Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
9.3 Viral Vector Technology
9.3.1 Overview
9.3.2 Viral Vector Technology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Genome Editing Technology
9.4.1 Overview
9.4.2 Genome Editing Technology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Somatic Cell Technology
9.5.1 Overview
9.5.2 Somatic Cell Technology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
9.6 Cell Immortalization Technology
9.6.1 Overview
9.6.2 Cell Immortalization Technology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
9.7 Cell Plasticity Technology
9.7.1 Overview
9.7.2 Cell Plasticity Technology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
9.8 Three-Dimensional Technology
9.8.1 Overview
9.8.2 Three-Dimensional Technology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
10. Cell Therapy Market – By Application
10.1 Overview
10.2 Cell Therapy Market, by Application, 2019 and 2027 (%)
10.2.1 North America Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.3 Oncology
10.3.1 Overview
10.3.2 Oncology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
10.4 Cardiovascular
10.4.1 Overview
10.4.2 Cardiovascular: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
10.5 Orthopedic
10.5.1 Overview
10.5.2 Orthopedic: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
10.6 Wound Management
10.6.1 Overview
10.6.2 Wound Management: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
10.7 Other Applications
10.7.1 Overview
10.7.2 Other Applications: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
11. Cell Therapy Market – By End User
11.1 Overview
11.2 Cell Therapy Market, by End User, 2019 and 2027 (%)
11.2.1 North America Cell Therapy Market, by End User – Revenue and Forecast to 2027 (USD Million)
11.3 Hospitals
11.3.1 Overview
11.3.2 Hospitals: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
11.4 Research Institutes
11.4.1 Overview
11.4.2 Research Institutes: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
12. Cell Therapy Market– Regional Analysis
12.1 North America: Cell Therapy Market
12.1.1 Overview
12.1.2 North America: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.3 North America: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
12.1.4 North America: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
12.1.5 North America: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
12.1.6 North America: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
12.1.7 North America: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
12.1.8 North America: Cell Therapy Market, by Country, 2019 & 2027 (%)
12.1.9 US: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.9.1 US: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.9.2 US: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
12.1.9.3 US: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
12.1.9.4 US: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
12.1.9.5 US: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
12.1.9.6 US: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
12.1.10 Canada: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.10.1 Canada: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.10.2 Canada: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
12.1.10.3 Canada: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
12.1.10.4 Canada: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
12.1.10.5 Canada: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
12.1.10.6 Canada: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
12.1.11 Mexico: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.11.1 Mexico: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.11.2 Mexico: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
12.1.11.3 Mexico: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
12.1.11.4 Mexico: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
12.1.11.5 Mexico: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
12.1.11.6 Mexico: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
13. Impact of COVID-19 Pandemic on North America Cell Therapy Market
13.1 North America: Impact Assessment of COVID-19 Pandemic
14. Cell therapy Market–Key Company Profiles
14.1 Vericel Corporation
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 MEDIPOST
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 NuVasive, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Mesoblast Limited
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Smith & Nephew
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Bristol-Myers Squibb Company
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Stemedica Cell Technologies, Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Castle Creek Biosciences, Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
Table 2. North America Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 3. North America Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 4. North America Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 5. North America Cell Therapy Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 6. North America: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
Table 7. North America: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 8. North America: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 9. North America: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 10. North America: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
Table 11. US: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
Table 12. US: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 13. US: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 14. US: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 15. US: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
Table 16. Canada: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
Table 17. Canada: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 18. Canada: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 19. Canada: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 20. Canada: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
Table 21. Mexico: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
Table 22. Mexico: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 23. Mexico: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 24. Mexico: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 25. Mexico: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
Table 26. Glossary of Terms, Cell Therapy Market
LIST OF FIGURES
Figure 1. Cell Therapy Market Segmentation
Figure 2. Cell Therapy Market Segmentation – By Region
Figure 3. North America Cell Therapy Market Overview
Figure 4. Allogeneic Segment Held Largest Share Of Therapy Type Segment In The Cell Therapy Market
Figure 5. US Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. North America Cell Therapy Market – Revenue Forecast And Analysis – 2019- 2027
Figure 8. Market Positioning Of Key Players In Cell Therapy Market
Figure 9. Cell Therapy Market Revenue Share, by Therapy Type, 2019 and 2027 (%)
Figure 10. Allogeneic: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Autologous: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Cell Therapy Market, by Product 2019 and 2027 (%)
Figure 13. Consumables: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Equipment: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Systems and Software: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Cell Therapy Market, by Technology, 2019 and 2027 (%)
Figure 17. Viral Vector Technology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Genome Editing Technology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Somatic Cell Technology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Cell Immortalization Technology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Cell Plasticity Technology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Three-Dimensional Technology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Cell Therapy Market, by Application, 2019 and 2027 (%)
Figure 24. Oncology: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Cardiovascular: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Orthopedic: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Wound Management: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Other Applications: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 29. Cell Therapy Market, by End User, 2019 and 2027 (%)
Figure 30. Hospitals Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 31. Research Institutes: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 32. Others: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 33. North America: Cell Therapy Market, by Key Country – Revenue (2019) (USD Million)
Figure 34. North America: Cell Therapy Market Revenue and Forecast to 2027 (USD Million)
Figure 35. North America: Cell Therapy Market, by Country, 2019 & 2027 (%)
Figure 36. US: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. Canada: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. Mexico: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
Figure 39. Impact of COVID-19 Pandemic in North American Country Markets
- Vericel Corporation
- MEDIPOST
- NuVasive, Inc
- Mesoblast Limited
- Smith & Nephew
- Bristol-Myers Squibb Company
- Stemedica Cell Technologies, Inc
- Castle Creek Biosciences, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to North America Cell Therapy Market
Feb 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Feb 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Feb 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Feb 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Feb 2021